Keywords
Last Name

Vladimir Gabai, PhD

TitleResearch Assistant Professor
InstitutionBoston University School of Medicine
DepartmentBiochemistry
Address72 E. Concord St Silvio Conte (K)
Boston MA 02118
Phone(617) 638-5970
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM. Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors. Oncotarget. 2017 Mar 25. PMID: 28388548.
    View in: PubMed
  2. Gabai VL, Yaglom JA, Wang Y, Meng L, Shao H, Kim G, Colvin T, Gestwicki J, Sherman MY. Anticancer Effects of Targeting Hsp70 in Tumor Stromal Cells. Cancer Res. 2016 Oct 15; 76(20):5926-5932. PMID: 27503927.
    View in: PubMed
  3. Sabbieti MG, Agas D, Capitani M, Marchetti L, Concetti A, Vullo C, Catone G, Gabai V, Shifrin V, Sherman MY, Shneider A, Venanzi FM. Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent. Oncotarget. 2015 Feb 28; 6(6):3590-9. PMID: 25668818.
    View in: PubMed
  4. Gabai V, Venanzi FM, Bagashova E, Rud O, Mariotti F, Vullo C, Catone G, Sherman MY, Concetti A, Chursov A, Latanova A, Shcherbinina V, Shifrin V, Shneider A. Pilot study of p62 DNA vaccine in dogs with mammary tumors. Oncotarget. 2014 Dec 30; 5(24):12803-10. PMID: 25296974.
    View in: PubMed
  5. Sherman MY, Gabai VL. Hsp70 in cancer: back to the future. Oncogene. 2015 Aug 6; 34(32):4153-61. PMID: 25347739.
    View in: PubMed
  6. Gabai VL, Shifrin VI. Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy. Int Rev Immunol. 2014 Oct; 33(5):375-82. PMID: 25277339.
    View in: PubMed
  7. Colvin TA, Gabai VL, Gong J, Calderwood SK, Li H, Gummuluru S, Matchuk ON, Smirnova SG, Orlova NV, Zamulaeva IA, Garcia-Marcos M, Li X, Young ZT, Rauch JN, Gestwicki JE, Takayama S, Sherman MY. Hsp70-Bag3 interactions regulate cancer-related signaling networks. Cancer Res. 2014 Sep 1; 74(17):4731-40. PMID: 24994713.
    View in: PubMed
  8. Colvin TA, Gabai VL, Sherman MY. Proteotoxicity is not the reason for the dependence of cancer cells on the major chaperone Hsp70. Cell Cycle. 2014; 13(14):2306-10. PMID: 24911412.
    View in: PubMed
  9. Zaarur N, Meriin AB, Bejarano E, Xu X, Gabai VL, Cuervo AM, Sherman MY. Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport. Mol Cell Biol. 2014 Apr; 34(7):1336-48. PMID: 24469403.
    View in: PubMed
  10. Venanzi F, Shifrin V, Sherman M, Gabai V, Kiselev O, Komissarov A, Grudinin M, Shartukova M, Romanovskaya-Romanko EA, Kudryavets Y, Bezdenezhnykh N, Lykhova O, Semesyuk N, Concetti A, Tsyb A, Filimonova M, Makarchuk V, Yakubovsky R, Chursov A, Shcherbinina V, Shneider A. Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector. Oncotarget. 2013 Oct; 4(10):1829-35. PMID: 24121124.
    View in: PubMed
  11. Kim G, Meriin AB, Gabai VL, Christians E, Benjamin I, Wilson A, Wolozin B, Sherman MY. The heat shock transcription factor Hsf1 is downregulated in DNA damage-associated senescence, contributing to the maintenance of senescence phenotype. Aging Cell. 2012 Aug; 11(4):617-27. PMID: 22510478.
    View in: PubMed
  12. Gabai VL, Meng L, Kim G, Mills TA, Benjamin IJ, Sherman MY. Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR. Mol Cell Biol. 2012 Mar; 32(5):929-40. PMID: 22215620.
    View in: PubMed
  13. Sherman MY, Meng L, Stampfer M, Gabai VL, Yaglom JA. Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells. Aging Cell. 2011 Dec; 10(6):949-61. PMID: 21824272.
    View in: PubMed
  14. Meng L, Hunt C, Yaglom JA, Gabai VL, Sherman MY. Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene. 2011 Jun 23; 30(25):2836-45. PMID: 21297664.
    View in: PubMed
  15. Kabakov AE, Kudryavtsev VA, Gabai VL. Determination of cell survival or death. Methods Mol Biol. 2011; 787:231-44. PMID: 21898239.
    View in: PubMed
  16. Meng L, Gabai VL, Sherman MY. Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene. 2010 Sep 16; 29(37):5204-13. PMID: 20622894.
    View in: PubMed
  17. Gabai VL, Sherman MY, Yaglom JA. HSP72 depletion suppresses gammaH2AX activation by genotoxic stresses via p53/p21 signaling. Oncogene. 2010 Apr 1; 29(13):1952-62. PMID: 20062073.
    View in: PubMed
  18. Proskuryakov SY, Gabai VL. Mechanisms of tumor cell necrosis. Curr Pharm Des. 2010 Jan; 16(1):56-68. PMID: 20214618.
    View in: PubMed
  19. Kabakov AE, Kudryavtsev VA, Gabai VL. Hsp90 inhibitors as promising agents for radiotherapy. J Mol Med (Berl). 2010 Mar; 88(3):241-7. PMID: 19946660.
    View in: PubMed
  20. Ilyinskii PO, Nurminskaya MV, Gabai VL, Prilipov AG, Usachev EV, Zakharova LG, Thoidis G, Altstein AD, Shneider AM. Effective expression of recombinant cytotoxic protein via its attachment to a polyglutamine domain. OMICS. 2009 Jun; 13(3):211-7. PMID: 19441878.
    View in: PubMed
  21. Gabai VL, Yaglom JA, Waldman T, Sherman MY. Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol. 2009 Jan; 29(2):559-69. PMID: 19001088.
    View in: PubMed
  22. Zaarur N, Meriin AB, Gabai VL, Sherman MY. Triggering aggresome formation. Dissecting aggresome-targeting and aggregation signals in synphilin 1. J Biol Chem. 2008 Oct 10; 283(41):27575-84. PMID: 18635553.
    View in: PubMed
  23. Ilyinskii PO, Meriin AB, Gabai VL, Usachev EV, Prilipov AG, Thoidis G, Shneider AM. The proteosomal degradation of fusion proteins cannot be predicted from the proteosome susceptibility of their individual components. Protein Sci. 2008 Jun; 17(6):1077-85. PMID: 18411420.
    View in: PubMed
  24. Gabai VL, O'Callaghan-Sunol C, Meng L, Sherman MY, Yaglom J. Triggering senescence programs suppresses Chk1 kinase and sensitizes cells to genotoxic stresses. Cancer Res. 2008 Mar 15; 68(6):1834-42. PMID: 18339864.
    View in: PubMed
  25. Ilyinskii PO, Meriin AB, Gabai VL, Zhirnov OP, Thoidis G, Shneider AM. Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response. Vaccine. 2008 Apr 24; 26(18):2177-85. PMID: 18400345.
    View in: PubMed
  26. Ilyinskii PO, Gambaryan AS, Meriin AB, Gabai V, Kartashov A, Thoidis G, Shneider AM. Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency. PLoS One. 2008; 3(1):e1417. PMID: 18197240.
    View in: PubMed
  27. O'Callaghan-Sunol C, Gabai VL, Sherman MY. Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res. 2007 Dec 15; 67(24):11779-88. PMID: 18089808.
    View in: PubMed
  28. Ilyinskii PO, Gabai VL, Sunyaev SR, Thoidis G, Shneider AM. Toxicity of influenza A virus matrix protein 2 for mammalian cells is associated with its intrinsic proton-channeling activity. Cell Cycle. 2007 Aug 15; 6(16):2043-7. PMID: 17700063.
    View in: PubMed
  29. Sherman MY, Sherman M, Gabai V, O'Callaghan C, Yaglom J. Molecular chaperones regulate p53 and suppress senescence programs. FEBS Lett. 2007 Jul 31; 581(19):3711-5. PMID: 17555746.
    View in: PubMed
  30. Yaglom JA, Gabai VL, Sherman MY. High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res. 2007 Mar 1; 67(5):2373-81. PMID: 17332370.
    View in: PubMed
  31. Sherman MY, Gabai VL. Multiple thermometers in mammalian cells: why do cells from homeothermic organisms need to measure temperature? Sci STKE. 2006 Mar 28; 2006(328):pe16. PMID: 16569818.
    View in: PubMed
  32. Zaarur N, Gabai VL, Porco JA, Calderwood S, Sherman MY. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res. 2006 Feb 1; 66(3):1783-91. PMID: 16452239.
    View in: PubMed
  33. Ruchalski K, Mao H, Li Z, Wang Z, Gillers S, Wang Y, Mosser DD, Gabai V, Schwartz JH, Borkan SC. Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J Biol Chem. 2006 Mar 24; 281(12):7873-80. PMID: 16407317.
    View in: PubMed
  34. Proskuriakov SIa, Konopliannikov AG, Gabai VL. [Cellular necrosis in genesis and therapy of diseases]. Ter Arkh. 2006; 78(1):65-9. PMID: 16512449.
    View in: PubMed
  35. Proskuryakov SY, Gabai VL, Konoplyannikov AG, Zamulaeva IA, Kolesnikova AI. Immunology of apoptosis and necrosis. Biochemistry (Mosc). 2005 Dec; 70(12):1310-20. PMID: 16417452.
    View in: PubMed
  36. Gabai VL, Budagova KR, Sherman MY. Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene. 2005 May 5; 24(20):3328-38. PMID: 15735699.
    View in: PubMed
  37. Yaglom JA, Ekhterae D, Gabai VL, Sherman MY. Regulation of necrosis of H9c2 myogenic cells upon transient energy deprivation. Rapid deenergization of mitochondria precedes necrosis and is controlled by reactive oxygen species, stress kinase JNK, HSP72 and ARC. J Biol Chem. 2003 Dec 12; 278(50):50483-96. PMID: 14523009.
    View in: PubMed
  38. Yaglom J, O'Callaghan-Sunol C, Gabai V, Sherman MY. Inactivation of dual-specificity phosphatases is involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp72. Mol Cell Biol. 2003 Jun; 23(11):3813-24. PMID: 12748284.
    View in: PubMed
  39. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res. 2003 Feb 1; 283(1):1-16. PMID: 12565815.
    View in: PubMed
  40. Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM. Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res. 2002 Nov; 8(11):3579-83. PMID: 12429649.
    View in: PubMed
  41. Gabai VL, Mabuchi K, Mosser DD, Sherman MY. Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis. Mol Cell Biol. 2002 May; 22(10):3415-24. PMID: 11971973.
    View in: PubMed
  42. Gabai VL, Sherman MY. Invited review: Interplay between molecular chaperones and signaling pathways in survival of heat shock. J Appl Physiol (1985). 2002 Apr; 92(4):1743-8. PMID: 11896044.
    View in: PubMed
  43. Proskuryakov SY, Gabai VL, Konoplyannikov AG. Necrosis is an active and controlled form of programmed cell death. Biochemistry (Mosc). 2002 Apr; 67(4):387-408. PMID: 11996653.
    View in: PubMed
  44. Meriin AB, Mabuchi K, Gabai VL, Yaglom JA, Kazantsev A, Sherman MY. Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1. J Cell Biol. 2001 May 14; 153(4):851-64. PMID: 11352944.
    View in: PubMed
  45. Gabai VL, Meriin AB, Yaglom JA, Wei JY, Mosser DD, Sherman MY. Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stewss-induced inhibition of JNK dephosphorylation. J Biol Chem. 2000 Dec 1; 275(48):38088-94. PMID: 10978340.
    View in: PubMed
  46. Gabai VL, Yaglom JA, Volloch V, Meriin AB, Force T, Koutroumanis M, Massie B, Mosser DD, Sherman MY. Hsp72-mediated suppression of c-Jun N-terminal kinase is implicated in development of tolerance to caspase-independent cell death. Mol Cell Biol. 2000 Sep; 20(18):6826-36. PMID: 10958679.
    View in: PubMed
  47. Volloch V, Gabai VL, Rits S, Force T, Sherman MY. HSP72 can protect cells from heat-induced apoptosis by accelerating the inactivation of stress kinase JNK. Cell Stress Chaperones. 2000 Apr; 5(2):139-47. PMID: 11147965.
    View in: PubMed
  48. Volloch V, Gabai VL, Rits S, Sherman MY. ATPase activity of the heat shock protein hsp72 is dispensable for its effects on dephosphorylation of stress kinase JNK and on heat-induced apoptosis. FEBS Lett. 1999 Nov 12; 461(1-2):73-6. PMID: 10561499.
    View in: PubMed
  49. Yaglom JA, Gabai VL, Meriin AB, Mosser DD, Sherman MY. The function of HSP72 in suppression of c-Jun N-terminal kinase activation can be dissociated from its role in prevention of protein damage. J Biol Chem. 1999 Jul 16; 274(29):20223-8. PMID: 10400639.
    View in: PubMed
  50. Meriin AB, Yaglom JA, Gabai VL, Zon L, Ganiatsas S, Mosser DD, Zon L, Sherman MY. Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72. Mol Cell Biol. 1999 Apr; 19(4):2547-55. PMID: 10082520.
    View in: PubMed
  51. Gabai VL, Meriin AB, Yaglom JA, Volloch VZ, Sherman MY. Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging. FEBS Lett. 1998 Oct 30; 438(1-2):1-4. PMID: 9821948.
    View in: PubMed
  52. Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J Biol Chem. 1998 Mar 13; 273(11):6373-9. PMID: 9497367.
    View in: PubMed
  53. Zamulaeva IA, Lekakh IV, Kiseleva VI, Gabai VL, Saenko AS, Shevchenko AS, Poverenny AM. Natural hidden antibodies reacting with DNA or cardiolipin bind to thymocytes and evoke their death. FEBS Lett. 1997 Aug 18; 413(2):231-5. PMID: 9280287.
    View in: PubMed
  54. Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI, Sherman MY. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem. 1997 Jul 18; 272(29):18033-7. PMID: 9218432.
    View in: PubMed
  55. Shevchenko AS, Gabai VL, Kobialko VO, Makarova IuM, Shevchenko TS. [Increased plasma membrane permeability for Ca2+ in radiation-induced thymocyte apoptosis]. Radiats Biol Radioecol. 1997 Mar-Apr; 37(2):220-7. PMID: 9181965.
    View in: PubMed
  56. Shevchenko AS, Gabai VL, Shevchenko TS, Aleksakhin RM. [Disruption of plasma cell membrane permeability for Ca2+ ions in radiation-induced apoptosis of thymocytes]. Dokl Akad Nauk. 1997 Mar; 353(2):284-6. PMID: 9244495.
    View in: PubMed
  57. Loktionova SA, Ilyinskaya OP, Gabai VL, Kabakov AE. Distinct effects of heat shock and ATP depletion on distribution and isoform patterns of human Hsp27 in endothelial cells. FEBS Lett. 1996 Aug 26; 392(2):100-4. PMID: 8772183.
    View in: PubMed
  58. Gabai VL, Zamulaeva IV, Mosin AF, Makarova YM, Mosina VA, Budagova KR, Malutina YV, Kabakov AE. Resistance of Ehrlich tumor cells to apoptosis can be due to accumulation of heat shock proteins. FEBS Lett. 1995 Nov 13; 375(1-2):21-6. PMID: 7498472.
    View in: PubMed
  59. Kabakov AE, Molotkov AO, Budagova KR, Makarova YuM, Mosin AF, Gabai VL. Adaptation of Ehrlich ascites carcinoma cells to energy deprivation in vivo can be associated with heat shock protein accumulation. J Cell Physiol. 1995 Oct; 165(1):1-6. PMID: 7559791.
    View in: PubMed
  60. Gabai VL, Mosina VA, Makarova IuM, Maliutina IaV, Budagova KR, Mosin AF. [Lack of serum causes apoptosis of thymocytes not requiring protein synthesis and ATP generation]. Biokhimiia. 1995 Aug; 60(8):1201-8. PMID: 7578574.
    View in: PubMed
  61. Dedov VN, Gabai VL, Cherniak BV. [Effect of protein inhibitors of mitochondrial ATPase in intact rat thymocytes and Ehrlich ascites carcinoma cells]. Biokhimiia. 1995 Jul; 60(7):1138-45. PMID: 7578568.
    View in: PubMed
  62. Kabakov AE, Gabai VL. Heat shock-induced accumulation of 70-kDa stress protein (HSP70) can protect ATP-depleted tumor cells from necrosis. Exp Cell Res. 1995 Mar; 217(1):15-21. PMID: 7867713.
    View in: PubMed
  63. Gabai VL, Mosina VA, Budagova KR, Kabakov AE. Spontaneous overexpression of heat-shock proteins in Ehrlich ascites carcinoma cells during in vivo growth. Biochem Mol Biol Int. 1995 Jan; 35(1):95-102. PMID: 7735144.
    View in: PubMed
  64. Kabakov AE, Gabai VL. Heat-shock proteins maintain the viability of ATP-deprived cells: what is the mechanism? Trends Cell Biol. 1994 Jun; 4(6):193-6. PMID: 14731676.
    View in: PubMed
  65. Gabai VL, Kabakov AE, Makarova IuM, Mosina VA, Mosin AF. [Fragmentation of Ehrlich ascites carcinoma DNA during influences causing aggregation of cytoskeletal proteins]. Biokhimiia. 1994 Apr; 59(4):551-8. PMID: 8018777.
    View in: PubMed
  66. Gabai VL, Kabakov AE. Induction of heat-shock protein synthesis and thermotolerance in EL-4 ascites tumor cells by transient ATP depletion after ischemic stress. Exp Mol Pathol. 1994 Apr; 60(2):88-99. PMID: 8070544.
    View in: PubMed
  67. Kabakov AE, Gabai VL. Stress-induced insolubilization of certain proteins in ascites tumor cells. Arch Biochem Biophys. 1994 Mar; 309(2):247-53. PMID: 8135534.
    View in: PubMed
  68. Chernyak BV, Dedov VN, Gabai VL. Mitochondrial ATP hydrolysis and ATP depletion in thymocytes and Ehrlich ascites carcinoma cells. FEBS Lett. 1994 Jan 3; 337(1):56-9. PMID: 8276114.
    View in: PubMed
  69. Mosin AF, Gabai VL, Makarova IuM, Mosina VA. [Damage to and interphase death of Ehrlich ascites carcinoma tumor cells at different growth stages during energy starvation and heat shock]. Tsitologiia. 1994; 36(4):384-92. PMID: 7809976.
    View in: PubMed
  70. Gabai VL. Inhibition of uncoupled respiration in tumor cells. A possible role of mitochondrial Ca2+ efflux. FEBS Lett. 1993 Aug 23; 329(1-2):67-71. PMID: 7689064.
    View in: PubMed
  71. Kabakov AE, Gabai VL. Protein aggregation as primary and characteristic cell reaction to various stresses. Experientia. 1993 Aug 15; 49(8):706-13. PMID: 8359277.
    View in: PubMed
  72. Gabai VL, Kabakov AE. Rise in heat-shock protein level confers tolerance to energy deprivation. FEBS Lett. 1993 Aug 2; 327(3):247-50. PMID: 8348950.
    View in: PubMed
  73. Gabai VL, Kabakov AE. Tumor cell resistance to energy deprivation and hyperthermia can be determined by the actin skeleton stability. Cancer Lett. 1993 Jun 15; 70(1-2):25-31. PMID: 8330297.
    View in: PubMed
  74. Gabai VL. Glucose decreases respiratory control ratio in EL-4 tumor cells. FEBS Lett. 1992 Nov 23; 313(2):126-8. PMID: 1426278.
    View in: PubMed
  75. Gabai VL, Kabakov AE, Mosin AF. Association of blebbing with assembly of cytoskeletal proteins in ATP-depleted EL-4 ascites tumour cells. Tissue Cell. 1992; 24(2):171-7. PMID: 1589868.
    View in: PubMed
  76. Gabai VL, Mosin AF. [Change in energy metabolism of ascites cancer cells with a decrease in pH]. Biokhimiia. 1991 Sep; 56(9):1652-60. PMID: 1747427.
    View in: PubMed
  77. Gabai VL, Mosin AF, Poverennyi AM. [Increasing the concentration of free calcium in thymocytes during gamma-irradiation may induce their death]. Radiobiologiia. 1990 Nov-Dec; 30(6):837-9. PMID: 2270289.
    View in: PubMed
  78. Gabai VL, Seilanov AS, Makarova YuM, Mosin AF. Oxidative stress, disturbance of energy balance, and death of ascites tumour cells under menadione (vitamin K3) action. Biomed Sci. 1990 Apr; 1(4):407-13. PMID: 2133060.
    View in: PubMed
  79. Gabai VL, Makarova IuM, Guliaev VA, Mosin AF. [The relationship of damage to and death of ascitic tumor cells during starvation to the ATP and free calcium content in the cells]. Tsitologiia. 1990; 32(7):712-9. PMID: 2260224.
    View in: PubMed
  80. Proskurikov SIa, Gabai VL, Mosin AF, Riabchenko NI. [DNA degradation and changes in the permeability and form of Ehrlich ascites tumor cells when incubated in an anaerobic medium without glucose]. Tsitologiia. 1989 Jun; 31(6):690-5. PMID: 2479156.
    View in: PubMed
Vladimir's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department